Omega Fund Management

Omega Fund Management as of Dec. 31, 2020

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 19 positions in its portfolio as reported in the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Common Stock (REPL) 29.0 $194M 5.1M 38.15
Kronos Bio Common Stock (KRON) 17.1 $114M 3.8M 29.87
Morphic Holding Common Stock (MORF) 14.7 $98M 2.9M 33.55
Spruce Biosciences Common Stock (SPRB) 7.9 $53M 2.2M 24.31
Atea Pharmaceuticals Common Stock (AVIR) 5.3 $35M 847k 41.78
Gossamer Bio Common Stock (GOSS) 4.8 $32M 3.3M 9.67
Immunic Common Stock (IMUX) 4.1 $27M 1.8M 15.29
Checkmate Pharmaceuticals Common Stock 2.9 $20M 1.3M 14.59
Arcutis Biothereapeutics Common Stock (ARQT) 2.7 $18M 640k 28.13
Syros Pharmaceuticals Common Stock 2.5 $17M 1.6M 10.85
Paratek Pharmaceuticals Common Stock 2.4 $16M 2.6M 6.26
Alpine Immune Sciences Common Stock 2.4 $16M 1.3M 12.60
ESSA Pharma Common Stock (EPIX) 1.3 $8.4M 706k 11.93
FibroGen Common Stock (FGEN) 0.7 $4.8M 131k 37.09
Cidara Therapeutics Common Stock 0.6 $4.0M 2.0M 2.00
Trevi Therapeutics Common Stock (TRVI) 0.5 $3.3M 1.3M 2.64
Jounce Therapeutics Common Stock 0.4 $2.3M 335k 7.00
ObsEva Common Stock 0.3 $2.1M 999k 2.08
Pieris Pharmaceuticals Common Stock 0.3 $1.9M 751k 2.50